Biotech FDA Accepts BLA for TLX250-CDx (Zircaix®) for Kidney Cancer Imaging, Grants Priority Review February 26, 2025
Biotech NMPA Accepts NDA and Grants Priority Review Designation to Innovent’s Ipilimumab Injection, China’s First Domestic CTLA-4 Inhibitor, in Combination with Sintilimab as Neoadjuvant Treatment for Colon Cancer February 24, 2025
Biotech Esphera SynBio’s Exosome Tech Featured on Advancements with Ted Danson on the Bloomberg cable and satellite network February 23, 2025
Biotech FDA Approves First Treatment for Cerebrotendinous Xanthomatosis, a Rare Lipid Storage Disease February 22, 2025
Biotech Alamar Biosciences Launches Certified Service Provider Program to Expand Access to NULISA technology for Academic and Biopharmaceutical Researchers February 21, 2025
Biotech Global Influenza Vaccine Market is Projected to Cross USD 14 Billion Mark by 2032 | DelveInsight February 21, 2025
Biotech Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer February 18, 2025
Biotech DAAN Biotherapeutics Signs Antibody Exclusive Licensing Agreement with LigaChem Biosciences for ADC (Antibody-Drug Conjugate) Therapeutic Development February 13, 2025
Search
Biotech
February 27, 2025
February 26, 2025
February 25, 2025
February 24, 2025
February 23, 2025
February 22, 2025
February 21, 2025
February 21, 2025
February 18, 2025
February 13, 2025
